Cargando…
IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496607/ https://www.ncbi.nlm.nih.gov/pubmed/32419137 http://dx.doi.org/10.1111/bjh.16710 |
| _version_ | 1783583135360876544 |
|---|---|
| author | Leisch, Michael Greil, Richard Pleyer, Lisa |
| author_facet | Leisch, Michael Greil, Richard Pleyer, Lisa |
| author_sort | Leisch, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7496607 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74966072020-09-25 IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? Leisch, Michael Greil, Richard Pleyer, Lisa Br J Haematol Commentary John Wiley and Sons Inc. 2020-05-17 2020-08 /pmc/articles/PMC7496607/ /pubmed/32419137 http://dx.doi.org/10.1111/bjh.16710 Text en © 2020 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Commentary Leisch, Michael Greil, Richard Pleyer, Lisa IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? |
| title | IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? |
| title_full | IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? |
| title_fullStr | IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? |
| title_full_unstemmed | IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? |
| title_short | IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? |
| title_sort | ido in mds/aml disease progression and its role in resistance to azacitidine: a potential new drug target? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496607/ https://www.ncbi.nlm.nih.gov/pubmed/32419137 http://dx.doi.org/10.1111/bjh.16710 |
| work_keys_str_mv | AT leischmichael idoinmdsamldiseaseprogressionanditsroleinresistancetoazacitidineapotentialnewdrugtarget AT greilrichard idoinmdsamldiseaseprogressionanditsroleinresistancetoazacitidineapotentialnewdrugtarget AT pleyerlisa idoinmdsamldiseaseprogressionanditsroleinresistancetoazacitidineapotentialnewdrugtarget |